Parsonnet V, Bernstein A D, Galasso D
Department of Surgery, Newark Beth Israel Medical Center, New Jersey 07112.
Am J Cardiol. 1988 Jul 1;62(1):71-7. doi: 10.1016/0002-9149(88)91367-7.
Physicians active in pacemaker implantation and follow-up were surveyed to obtain a profile of permanent cardiac pacing practices in the United States during 1985. Questionnaires were sent to 628 physicians, mainly in New Jersey; 145 responses were received and analyzed. A separate questionnaire was sent to 9 pacemaker manufacturers to solicit information concerning the volume of pacemaker sales and their opinions on a variety of subjects. The rate of permanent pacemaker implantation declined for the first time: it dropped from 518 devices per million population in 1981 to 374 in 1985. Sinus node dysfunction was the chief indication for permanent pacing in 52% of primary implantations; conduction disorders of the atrioventricular node and His-Purkinje system accounted for 41% and ventricular tachyarrhythmias for 2%. Dual-chamber pacing modes were used less frequently than was predicted in 1981, accounting for 30% of primary and 19% of replacement pacemakers. More than 43% of programmable pulse generators were never reprogrammed after implantation. Surveys such as this continue to provide useful information despite obstacles encountered in the use of questionnaires. Important differences in practice patterns and outcomes were identified between surgeons and nonsurgeons, and between frequent and infrequent implanters. These differences reinforce the suggestion that implanters should work at a volume sufficient to maintain their expertise, and that cooperation between surgeons and nonsurgeons would lead to improvements in patient selection, surgical results and optimal pacemaker programming and follow-up care. Better results could be achieved by adopting the continent-wide system of a pacemaker registry now used in Eastern Europe and Great Britain.
对从事起搏器植入和随访工作的医生进行了调查,以了解1985年美国永久性心脏起搏治疗的情况。向主要来自新泽西州的628名医生发放了调查问卷;共收到145份回复并进行了分析。还向9家起搏器制造商发放了一份单独的调查问卷,以获取有关起搏器销售量以及他们对各种问题看法的信息。永久性起搏器植入率首次下降:从1981年每百万人口518台降至1985年的374台。在52%的初次植入中,窦房结功能障碍是永久性起搏的主要指征;房室结和希氏 - 浦肯野系统传导障碍占41%,室性快速心律失常占2%。双腔起搏模式的使用频率低于1981年的预测,占初次植入起搏器的30%和更换起搏器的19%。超过43%的可编程脉冲发生器在植入后从未重新编程。尽管在使用问卷过程中遇到了障碍,但这样的调查仍能持续提供有用信息。在外科医生和非外科医生之间,以及频繁植入者和不频繁植入者之间,发现了实践模式和结果的重要差异。这些差异进一步表明,植入者的工作量应足以维持其专业技能,并且外科医生和非外科医生之间的合作将有助于改善患者选择、手术结果以及优化起搏器编程和随访护理。采用目前东欧和英国使用的全欧洲范围的起搏器注册系统,可能会取得更好的结果。